search for: businesswir

...discover and develop targeted cancer therapeutics. The company's lead product, Tivozanib, is an oral, triple VEGF receptor inhibitor with potential for a best-in-class profile. Tivozanib is currently being investigated in a global, randomized Phase 3 clinical trial called TIVO-1 <http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ave opharma.com%2Ffor_patients%2F&esheet=6299494&lan=en_US&anchor=TIVO-1&ind ex=1&md5=445a20da41b339efa84d364a08f882ec> comparing Tivozanib to Sorafenib in advanced kidney cancer, as well as additional clinical studies in othe...

Has anyone heard whether Revolution Analytics is going to release this capability to the R community? http://www.businesswire.com/news/home/20110201005852/en/Revolution-Analytics-Unlocks-SAS-Data Dan Daniel Nordlund Bothell, WA USA

Dear List, Sharepoint sites are used more and more often by researchers as a platform to share all the information in a joint research project. Typically, they can be accessed only by a Hypertext Transfer Protocol Secure (HTTPS) URL. We are investigating whether it is possible to read and write data to Microsoft Sharepoint sites using R. We have managed to open a read-only connection to read

I have been frustrated with J2EE technology just like any other developer who has worked in that technology for a long time. This made me learn about Rails and I was excited about RoR. Today I came across JBoss Seam framework and I am not able to contain my excitement. My passion for JEE development is back. It seems like it is better than RoR. I would like to hear differnt opinions about this